BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6712858)

  • 1. Comparison of the effects of prizidilol and propranolol on renal haemodynamics at rest and during exercise.
    Malini PL; Strocchi E; Ambrosioni E
    Br J Clin Pharmacol; 1984 Mar; 17(3):251-5. PubMed ID: 6712858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal haemodynamics after chronic treatment with labetalol and propranolol.
    Malini PL; Strocchi E; Negroni S; Ambrosioni E; Magnani B
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):123S-126S. PubMed ID: 7093095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary effects in man of oral prizidilol hydrochloride (SK&F 92657), a new antihypertensive agent.
    Edmondstone WM; Waller JF; Manghani KK; Hill PL; Bell AJ; Denison DM
    Br J Clin Pharmacol; 1983 Dec; 16(6):591-8. PubMed ID: 6140939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol and renal hemodynamics at rest and during exercise.
    Malini PL; Strocchi E; Ambrosioni E
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):611-4. PubMed ID: 6668099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of combined vasodilation and beta-adrenoceptor blockade with prizidilol on renal function.
    Boehringer K; Weidmann P; Link L; Bianchetti MG; Schiffl H; Reubi FC
    Br J Clin Pharmacol; 1983 Feb; 15(2):181-8. PubMed ID: 6133543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of prizidilol, a new antihypertensive drug with combined arteriolar vasodilator and beta-adrenoceptor blocking actions, with hydralazine and propranolol in conscious dogs with chronic atrioventricular block.
    Boucher M; Dubray C; Duchêne-Marullaz P
    J Cardiovasc Pharmacol; 1983; 5(5):712-6. PubMed ID: 6195455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of prizidilol hydrochloride (SK & F 92657), a new antihypertensive agent with beta-adrenoceptor antagonist and vasodilator activity with propranolol and hydralazine in normal volunteers.
    Steiner JA; Clancy A; Manghani KK; James IM
    Br J Clin Pharmacol; 1981 Oct; 12(4):573-8. PubMed ID: 6117309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular response to exercise and regional haemodynamics during treatment with prizidilol hydrochloride (SK & F 92 657) in moderately severe essential hypertension.
    Andersson O; Ljungman S; Berglund G
    Eur J Clin Pharmacol; 1983; 25(5):577-80. PubMed ID: 6662157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal function studies with propildazine alone and in combination with propranolol in dogs.
    Dorigotti L; Semeraro C
    Eur J Pharmacol; 1980 Oct; 67(2-3):275-82. PubMed ID: 7461034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular response to mental stress: dynamic and isometric exercise in hypertensive patients treated with prizidilol hydrochloride (SK&F 92657).
    Costa FV; Borghi C; Boschi S; Ambrosioni E
    Int J Clin Pharmacol Res; 1984; 4(5):373-9. PubMed ID: 6151553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension.
    Larsen JS; Pedersen EB
    Eur J Clin Pharmacol; 1980 Aug; 18(2):135-9. PubMed ID: 7428793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of enalapril on blood pressure and renal haemodynamics in essential hypertension.
    Navis GJ; de Jong PE; Donker AJ; de Zeeuw D
    Proc Eur Dial Transplant Assoc; 1983; 20():577-81. PubMed ID: 6318224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prizidilol in essential hypertension: long-term effects on plasma volume, extracellular fluid volume, and central hemodynamics at rest and during exercise.
    Lund-Johansen P; Omvik P
    J Cardiovasc Pharmacol; 1982; 4(6):1012-7. PubMed ID: 6185765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response relationship of prizidilol hydrochloride (SK&F 92657): a comparison between acute and chronic effects in patients with essential hypertension.
    Pedrinelli R; Abdel-Haq B; Magagna A; Leto di Priolo S; Simonini N; Salvetti A
    Int J Clin Pharmacol Res; 1984; 4(2):155-63. PubMed ID: 6147320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension.
    Pedersen EB; Larsen JS
    Postgrad Med J; 1980; 56 Suppl 2():27-32. PubMed ID: 7433339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of levosimendan on glomerular filtration rate, renal blood flow, and renal oxygenation after cardiac surgery with cardiopulmonary bypass: a randomized placebo-controlled study.
    Bragadottir G; Redfors B; Ricksten SE
    Crit Care Med; 2013 Oct; 41(10):2328-35. PubMed ID: 23921271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal hemodynamic effects of tertatolol in essential hypertension.
    Paillard F; Lantz B; Leviel F; Ardaillou R
    Am J Nephrol; 1986; 6 Suppl 2():40-4. PubMed ID: 2879472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sodium loading and exercise on renal haemodynamics and urinary sodium excretion in young patients with essential hypertension before and during propranolol treatment.
    Pedersen EB
    Acta Med Scand; 1977; 201(4):365-73. PubMed ID: 851045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.
    Sánchez RA; Marcó E; Gilbert HB; Raffaele P; Brito M; Giménez M; Moledo LI
    Drugs; 1985; 30 Suppl 1():49-58. PubMed ID: 2994987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal haemodynamics during propranolol treatment in patients with arterial hypertension and chronic renal failure.
    Jacobsen BA; Fjeldborg P
    Scand J Clin Lab Invest; 1986 May; 46(3):289-92. PubMed ID: 3715380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.